Cargando…

Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations

OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Basta, Tomasz, Knapp, Paweł, Blecharz, Paweł, Bodnar, Lubomir, Gawron, Iwona, Babczyk, Dorota, Piróg, Magdalena, Kluz, Tomasz, Markowska, Anna, Horbaczewska, Anna, Jach, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354992/
https://www.ncbi.nlm.nih.gov/pubmed/30703105
http://dx.doi.org/10.1371/journal.pone.0209901
_version_ 1783391284485947392
author Basta, Tomasz
Knapp, Paweł
Blecharz, Paweł
Bodnar, Lubomir
Gawron, Iwona
Babczyk, Dorota
Piróg, Magdalena
Kluz, Tomasz
Markowska, Anna
Horbaczewska, Anna
Jach, Robert
author_facet Basta, Tomasz
Knapp, Paweł
Blecharz, Paweł
Bodnar, Lubomir
Gawron, Iwona
Babczyk, Dorota
Piróg, Magdalena
Kluz, Tomasz
Markowska, Anna
Horbaczewska, Anna
Jach, Robert
author_sort Basta, Tomasz
collection PubMed
description OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatment in Poland, as well as the mortality rate of Polish women with CC, which is 70% higher than the average for European Union (EU) countries, justifies the hypothesis that treatment of CC in Poland deviates from the Polish and international recommendations. This article puts forward the current management of cervical cancer in Poland and discusses it in the context of ASCO guidelines. MATERIAL AND METHODS: A survey retrospective multicenter analysis of the medical records of 1247 patients with cervical cancer who underwent treatment for disease and who had completed at least two years of follow-up. RESULTS: Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. CONCLUSION: Within the IA to II A cervical cancer patients studied group, the methods of treatment remained in line with ASCO guidelines for countries with the highest standard of care. Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. Our findings, together with the inconsistencies within the cervical cancer screening program, may be one of the explanations of poorer survival rate of women with cervical cancer in Poland.
format Online
Article
Text
id pubmed-6354992
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63549922019-02-15 Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations Basta, Tomasz Knapp, Paweł Blecharz, Paweł Bodnar, Lubomir Gawron, Iwona Babczyk, Dorota Piróg, Magdalena Kluz, Tomasz Markowska, Anna Horbaczewska, Anna Jach, Robert PLoS One Research Article OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatment in Poland, as well as the mortality rate of Polish women with CC, which is 70% higher than the average for European Union (EU) countries, justifies the hypothesis that treatment of CC in Poland deviates from the Polish and international recommendations. This article puts forward the current management of cervical cancer in Poland and discusses it in the context of ASCO guidelines. MATERIAL AND METHODS: A survey retrospective multicenter analysis of the medical records of 1247 patients with cervical cancer who underwent treatment for disease and who had completed at least two years of follow-up. RESULTS: Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. CONCLUSION: Within the IA to II A cervical cancer patients studied group, the methods of treatment remained in line with ASCO guidelines for countries with the highest standard of care. Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. Our findings, together with the inconsistencies within the cervical cancer screening program, may be one of the explanations of poorer survival rate of women with cervical cancer in Poland. Public Library of Science 2019-01-31 /pmc/articles/PMC6354992/ /pubmed/30703105 http://dx.doi.org/10.1371/journal.pone.0209901 Text en © 2019 Basta et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Basta, Tomasz
Knapp, Paweł
Blecharz, Paweł
Bodnar, Lubomir
Gawron, Iwona
Babczyk, Dorota
Piróg, Magdalena
Kluz, Tomasz
Markowska, Anna
Horbaczewska, Anna
Jach, Robert
Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title_full Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title_fullStr Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title_full_unstemmed Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title_short Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
title_sort current management of cervical cancer in poland—analysis of the questionnaire trial for the years 2002-2014 in relation to asco 2016 recommendations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354992/
https://www.ncbi.nlm.nih.gov/pubmed/30703105
http://dx.doi.org/10.1371/journal.pone.0209901
work_keys_str_mv AT bastatomasz currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT knapppaweł currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT blecharzpaweł currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT bodnarlubomir currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT gawroniwona currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT babczykdorota currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT pirogmagdalena currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT kluztomasz currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT markowskaanna currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT horbaczewskaanna currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations
AT jachrobert currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations